Home › Funds › Lazard Freres Gestion S.A.S. › BSX

Lazard Freres Gestion S.A.S. position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Lazard Freres Gestion S.A.S. reported holding 248,254 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$10.8M, representing 0.18% of its reported portfolio and ranking #48 among its reported holdings. Lazard Freres Gestion S.A.S. has disclosed BSX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)248.25K sh
Reported value held$10.84M
Portfolio Weight0.18%
First reportedQ1 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Lazard Freres Gestion S.A.S.'s BSX position evolved

Lazard Freres Gestion S.A.S. first disclosed a stake in BSX in Q1 2026 at 217,486 shares (US$13.6M). Across 3 filings, Lazard Freres Gestion S.A.S. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 248,254 shares valued at US$10.8M — an increase of 7,141 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 217.49K $13.65M New
Q2 2026 241.11K $10.29M Add
Q3 2026 248.25K $10.84M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Lazard Freres Gestion S.A.S. held BSX?

Lazard Freres Gestion S.A.S. has disclosed BSX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Lazard Freres Gestion S.A.S.'s current position in BSX?

As of Q3 2026, Lazard Freres Gestion S.A.S. holds 248.25K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $10.84M, representing 0.18% of its reported portfolio and ranking #48.

Has Lazard Freres Gestion S.A.S. been buying or selling BSX?

In the latest 13F filing (Q3 2026), Lazard Freres Gestion S.A.S. increased its position in BSX.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.